The blood glucose-lowering effect of racecadotril is not attributable to inhibition of insulin-degrading enzyme

S. Kurklinsky, S. O. Abdul-Hay, M. P. McGuire, E. A. Howard, J. Knight, M. A. Leissring

Research output: Contribution to journal › Letter › peer-review

Fingerprint

Dive into the research topics of 'The blood glucose-lowering effect of racecadotril is not attributable to inhibition of insulin-degrading enzyme'. Together they form a unique fingerprint.